RESUMEN
Cannabinoid's major effect on movement is hypoactivity. Nevertheless, a biphasic excitatory/inhibitory effect of cannabinoids on movement has been repeatedly acknowledged. However, the literature is lacking a detailed description of such an effect. In this study, we performed a dose-response study of the effects of Delta(9)-tetrahydrocannabinol on movement. Immediately after the administration of vehicle or a dose of Delta(9)-tetrahydrocannabinol (0.2, 0.5, 1, 1.5, 2, 2.5, 3, 4, or 5 mg/kg), the animal was placed in an activity monitor and observed for 1 h. Several parameters were recorded. The horizontal and vertical activities were measured as the number of photobeams broken between the photocells on the walls of an activity monitor. The number of wet dog shakes, scratches with hindpaw, mouth movements, forepaw flutters were also recorded, as was the amount of time in minutes that each subject spent grooming. The number of fecal boluses was recorded as an index of autonomic activity. Each animal was subsequently tested for catalepsy in the bar test. A triphasic effect was observed: low doses of the cannabinoid receptor agonist Delta(9)-tetrahydrocannabinol (0.2 mg/kg) decreased locomotor activity while higher doses (1-2 mg/kg) dose-dependently stimulated movement until catalepsy emerged (2.5 mg/kg) accompanied by decreases in activity.
Asunto(s)
Cannabinoides/metabolismo , Dronabinol/farmacología , Actividad Motora/efectos de los fármacos , Receptores de Droga/agonistas , Animales , Catalepsia/inducido químicamente , Relación Dosis-Respuesta a Droga , Masculino , Ratas , Ratas Sprague-Dawley , Receptores de CannabinoidesRESUMEN
We studied the cellular distribution of CB1 cannabinoid receptors in the superior colliculus of the rat using an antibody raised against the N-terminal of the receptor. The effect of unilateral cannabinoid receptor stimulation in the intermediate layers of the superior colliculus on rotational behavior in rats was also explored. The antibody against CB1 receptors outlined the crossed descending system of the superior colliculus (predorsal bundle output system) as well as the collicular commisure. The potent cannabinoid agonist CP55,940 (5 microgram/0.25 microliter) induced strong contralateral turning when microinjected unilaterally into the lateral intermediate layers of the superior colliculus. The levels of turning obtained with the intracollicular administration of the cannabinoid were comparable to the highest levels obtained with dopamine agonists in the basal ganglia. The D(2) dopamine agonist quinpirole or the D(1) dopamine agonist SKF82958 reversed this contralateral rotation but failed to affect motor behavior on their own. A new motor pathway for cannabinoids is discussed.
Asunto(s)
Cannabinoides/farmacología , Dopamina/metabolismo , Actividad Motora/efectos de los fármacos , Receptores de Droga/metabolismo , Colículos Superiores/efectos de los fármacos , Colículos Superiores/metabolismo , Analgésicos/administración & dosificación , Animales , Conducta Animal/efectos de los fármacos , Benzazepinas/administración & dosificación , Cannabinoides/administración & dosificación , Cannabinoides/antagonistas & inhibidores , Ciclohexanoles/administración & dosificación , Agonistas de Dopamina/administración & dosificación , Masculino , Microinyecciones , Ratas , Ratas Sprague-Dawley , Receptores de Cannabinoides , Receptores de Dopamina D1/agonistas , Receptores de Dopamina D1/metabolismo , Receptores de Dopamina D2/agonistas , Receptores de Dopamina D2/metabolismo , Colículos Superiores/citologíaRESUMEN
Synthetic cannabinoids produce behavioral analgesia and suppress pain neurotransmission, raising the possibility that endogenous cannabinoids serve naturally to modulate pain. Here, the development of a sensitive method for measuring cannabinoids by atmospheric pressure-chemical ionization mass spectrometry permitted measurement of the release of the endogenous cannabinoid anandamide in the periaqueductal gray (PAG) by in vivo microdialysis in the rat. Electrical stimulation of the dorsal and lateral PAG produced CB1 cannabinoid receptor-mediated analgesia accompanied by a marked increase in the release of anandamide in the PAG, suggesting that endogenous anandamide mediates the behavioral analgesia. Furthermore, pain triggered by subcutaneous injections of the chemical irritant formalin substantially increased the release of anandamide in the PAG. These findings indicate that the endogenous cannabinoid anandamide plays an important role in a cannabinergic pain-suppression system existing within the dorsal and lateral PAG. The existence of a cannabinergic pain-modulatory system may have relevance for the treatment of pain, particularly in instances where opiates are ineffective.
Asunto(s)
Ácidos Araquidónicos/farmacología , Bloqueadores de los Canales de Calcio/farmacología , Cannabinoides/farmacología , Analgesia , Animales , Cannabinoides/antagonistas & inhibidores , Electrofisiología , Endocannabinoides , Formaldehído/farmacología , Cromatografía de Gases y Espectrometría de Masas , Humanos , Masculino , Microdiálisis , Modelos Biológicos , Dolor , Sustancia Gris Periacueductal/fisiología , Piperidinas/farmacología , Alcamidas Poliinsaturadas , Pirazoles/farmacología , Ratas , Ratas Sprague-Dawley , Rimonabant , Factores de TiempoRESUMEN
Localization of cannabinoid CB 1 receptors on GABAergic interneurons in the rat hippocampal formation was studied by double-labeling immunohistochemistry with confocal microscopy. Virtually all CB1-immunoreactive neurons (95%) are GABAergic. CB 1 fluorescence showed a punctate pattern. In contrast, the GABA fluorescence was distributed homogeneously, suggesting that while CB 1 receptors and GABA exist in the same cells they are not localized in the same subcellular compartments. Although virtually all CB1 neurons were GABAergic, many GABAergic neurons did not contain CB1 receptors. GABAergic interneurons in the hippocampal formation can be further divided into subpopulations with distinct connections and functions, using cell markers such as neuropeptides and calcium binding proteins. CB1 receptors were highly co-localized with cholecystokinin and partially co-localized with calretinin and calbindin, but not with parvalbumin. This suggests that cannabinoids may modulate GABAergic neurotransmission at the synapses on the soma and at synapses on the proximal dendrites of the principal neurons, as well as at synapses on other GABAergic interneurons.
Asunto(s)
Colecistoquinina/análisis , Hipocampo/metabolismo , Interneuronas/química , Proteínas del Tejido Nervioso/análisis , Receptores de Droga/análisis , Ácido gamma-Aminobutírico/análisis , Animales , Calbindina 2 , Calbindinas , Técnica del Anticuerpo Fluorescente Indirecta , Hipocampo/citología , Masculino , Parvalbúminas/análisis , Ratas , Ratas Sprague-Dawley , Receptores de Cannabinoides , Proteína G de Unión al Calcio S100/análisisRESUMEN
The levels of CB1 cannabinoid receptors in the basal ganglia are the highest in the brain, comparable to the levels of dopamine receptors, a major transmitter in the basal ganglia. This localization of receptors is consistent with the profound effects on motor function exerted by cannabinoids. The output nuclei of the basal ganglia, the globus pallidus (GP) and substantia nigra reticulata (SNr), apparently lack intrinsic cannabinoid receptors. Rather, the receptors are located on afferent terminals, the striatum being the major source. Cannabinoids blocked the inhibitory action of the striatal input in the SNr. Furthermore, cannabinoids blocked the excitatory effect of stimulation of the subthalamic input to the SNr revealing, along with data from in situ hybridization studies, that this input is another likely source of cannabinoid receptors to the SNr. Similar actions of cannabinoids were observed in the GP. Behavioral studies further revealed that the action of cannabinoids differs depending upon which input to the output nuclei of the basal ganglia is active. The inhibitory striatal input is quiescent and the cannabinoid action is observable only upon stimulation of the striatum, while the noticeable effect of cannabinoids under basal conditions would be on the tonically active subthalamic input. These data suggest that the recently discovered endogenous cannabinergic system exerts a major modulatory action in the basal ganglia by its ability to block both the major excitatory and inhibitory inputs to the SNr and GP.
Asunto(s)
Ganglios Basales/efectos de los fármacos , Ganglios Basales/fisiología , Cannabinoides/farmacología , Actividad Motora/efectos de los fármacos , Animales , Ganglios Basales/química , Globo Pálido/efectos de los fármacos , Globo Pálido/fisiología , Humanos , Receptores de Cannabinoides , Receptores de Droga/análisis , Receptores de Droga/fisiología , Sustancia Negra/efectos de los fármacos , Sustancia Negra/fisiologíaRESUMEN
AIM: The localization of CB1 receptors in the spinal cord, spinal roots, dorsal root ganglion (DRG), and peripheral nerve of the rat was determined. METHODS: We studied the distribution of CB1 cannabinoid receptors by immunohistochemistry using an antibody raised against the N-terminal of the receptor. RESULTS: The spinal cord showed numerous transverse fibers labelled for CB1 receptors throughout and concentrated in the dorsal horn. Lightly-stained cells were observed throughout the spinal cord gray matter. The DRG also showed cells and fibers labelled for CB1 receptors. Labelled fibers were observed in both dorsal and ventral roots as well as in peripheral nerves. CONCLUSION: The presence of CB1 receptors in the DRG, the dorsal root, and the dorsal horn is in accordance with the analgesic effects of cannabinoids. The presence of labelled cells and fibers in the ventral horn and ventral root provides a substrate for cannabinoid-induced muscle relaxant and antispastic effects.
Asunto(s)
Cannabinoides/metabolismo , Nervios Periféricos/metabolismo , Receptores de Droga/metabolismo , Médula Espinal/metabolismo , Raíces Nerviosas Espinales/metabolismo , Animales , Ganglios Espinales/metabolismo , Inmunohistoquímica , Masculino , Ratas , Ratas Sprague-Dawley , Receptores de CannabinoidesRESUMEN
AIM: To determine the dopaminergic system involvement in precipitated cannabinoid withdrawal syndrome. METHODS: The dopamine D1 receptor antagonist SCH23390 or the dopamine D2 receptor antagonist sulpiride was administered to rats chronically treated with either delta 9-tetrahydrocannabinol (THC) or vehicle. Subjects were then injected with either SR141716A or vehicle and behavior was observed for 1 h. RESULTS: Administration of the cannabinoid receptor antagonist SR141716A to animals chronically treated with THC as described by Tsou et al (1995) produced a profound withdrawal syndrome. Treatment with dopamine antagonists did not attenuate cannabinoid precipitated withdrawal syndrome in THC tolerant animals while the agonists increased the syndrome. CONCLUSION: It is unlikely that the dopaminergic system plays a major role in mediating the behavioral aspects of the cannabinoid withdrawal syndrome.
Asunto(s)
Cannabinoides/efectos adversos , Antagonistas de Dopamina/farmacología , Receptores de Droga/antagonistas & inhibidores , Síndrome de Abstinencia a Sustancias , Animales , Benzazepinas/farmacología , Dronabinol/farmacología , Masculino , Ratas , Ratas Sprague-Dawley , Receptores de CannabinoidesRESUMEN
The effect of unilateral intrastriatal cannabinoid receptor stimulation on rotational behavior in rats was explored. The potent cannabinoid agonist CP 55,940 (5 microg/0.5 microl) induced contralateral turning when microinjected unilaterally into the striatum. The D2 dopamine agonist quinpirole reversed this contralateral rotation but failed to affect motor behavior on its own. Finally, the D1 dopamine agonist SKF 82958 inhibited movement when administered into the striatum and this inhibition was reversed by co-administration of the cannabinoid agonist. Surprisingly, microinjections of the cannabinoid agonist into the striatum induced movement through activation of the striatonigral pathway and/or inhibition of the striatopallidal pathway, while the D1 dopamine agonist produced the opposite effect.
Asunto(s)
Cannabinoides/farmacología , Dopamina/fisiología , Neostriado/fisiología , Conducta Estereotipada/efectos de los fármacos , Animales , Benzazepinas/farmacología , Cannabinoides/administración & dosificación , Ciclohexanoles/farmacología , Agonistas de Dopamina/farmacología , Masculino , Neostriado/anatomía & histología , Quinpirol/farmacología , Ratas , Ratas Sprague-Dawley , Receptores de Cannabinoides , Receptores de Dopamina D1/agonistas , Receptores de Dopamina D2/agonistas , Receptores de Droga/agonistas , RotaciónRESUMEN
Cannabinoid receptors in the brain are highly concentrated in the basal ganglia, which is in accordance with their well known effects on motor behavior. In this study, rats with 6-hydroxydopamine lesions of the nigrostriatal pathway were implanted with cannulae in the striatum, globus pallidus and substantia nigra. The effect of unilateral infusion of the potent cannabinoid agonist CP55,940 on turning behavior was studied for each structure. Lesioned animals responded to intrapallidal and intrastriatal administration of the cannabinoid in a manner that was similar to that of unlesioned animals. However, lesioned animals showed greater contralateral turning in response to the cannabinoid infusions in the substantia nigra than unlesioned animals.
Asunto(s)
Ganglios Basales/efectos de los fármacos , Cannabinoides/farmacología , Enfermedad de Parkinson/fisiopatología , Animales , Ganglios Basales/fisiopatología , Cannabinoides/administración & dosificación , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/fisiopatología , Ciclohexanoles/farmacología , Globo Pálido/efectos de los fármacos , Globo Pálido/fisiopatología , Inyecciones Intraventriculares , Masculino , Actividad Motora/efectos de los fármacos , Vías Nerviosas/efectos de los fármacos , Vías Nerviosas/fisiopatología , Oxidopamina/farmacología , Ratas , Ratas Sprague-Dawley , Sustancia Negra/efectos de los fármacos , Sustancia Negra/fisiopatologíaRESUMEN
The subthalamic nucleus contains cannabinoid receptors and cannabinoid receptor mRNA. However, the role of cannabinoid receptors in this nucleus has not been examined. In order to investigate the functional role of cannabinoid receptors in the rat subthalamic nucleus, turning activity was observed following unilateral microinjection of the synthetic cannabinoid CP 55,940. CP 55,940 (10 microg) induced ipsilateral turning. This effect was blocked by coadministration of the cannabinoid receptor antagonist SR141716A (5 microg). These results suggest that cannabinoid receptors in the subthalamic nucleus mediate an inhibition of motor activity.
Asunto(s)
Conducta Animal/efectos de los fármacos , Cannabinoides/administración & dosificación , Microinyecciones , Núcleos Talámicos/efectos de los fármacos , Animales , Ciclohexanoles/antagonistas & inhibidores , Ciclohexanoles/farmacología , Lateralidad Funcional/efectos de los fármacos , Globo Pálido/fisiología , Inyecciones Intraventriculares , Masculino , Mesencéfalo/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Piperidinas/farmacología , Pirazoles/farmacología , Ratas , Ratas Sprague-Dawley , Receptores de Cannabinoides , Receptores de Droga/efectos de los fármacos , Receptores de Droga/fisiología , Rimonabant , Núcleos Talámicos/fisiologíaRESUMEN
Immunohistochemical distribution of cannabinoid receptors in the adult rat brain was studied using specific purified antibodies against the amino-terminus of the CB1 receptor. Our results generally agree well with the previous studies using CB1 receptor autoradiography and messenger RNA in situ hybridization. However, because of its greater resolution, immunohistochemistry allowed identification of particular neuronal cells and fibers that possess cannabinoid receptors. CB1-like immunoreactivity was found in axons, cell bodies and dendrites, where it appeared as puncta in somata and processes. Both intensely and moderately or lightly stained neurons were observed. The intensely stained neurons were dispersed and only occur in cortical structures including hippocampal formation and olfactory bulb. Moderately or lightly stained neurons were found in caudate-putamen and amygdala. In the hippocampal formation only intensely stained neurons were observed. The cell bodies of pyramidal neurons in CA1 and CA3 fields appeared to be unstained but surrounded by a dense plexus of immunoreactive fibers. The granule cells in the dentate area were also immunonegative. Many intensely stained neurons were located at the base of the granule cell layer. CB1-like immunoreactive neurons and fibers were also found in the somatosensory, cingulate, perirhinal, entorhinal and piriform cortices, in claustrum, amygdaloid nuclei, nucleus accumbens and septum. Beaded immunoreactive fibers were detected in periaqueductal gray, nucleus tractus solitarius, spinal trigeminal tract and nucleus, dorsal horn and lamina X of the spinal cord. A triangular cap-like mass of immunoreactivity was found to surround the basal part of the Purkinje cell body in the cerebellum. Only small, lightly stained cells were found in the molecular layer in the cerebellum close to the Purkinje cell layer. The CB1 receptor is widely distributed in the forebrain and has a more restricted distribution in the hindbrain and the spinal cord. It appears to be expressed on cell bodies, dendrites and axons. According to the location and morphology, many, but not all, CB1-like immunoreactive neurons appear to be GABAergic. Therefore, cannabinoids and cannabinoid receptors may play a role in modulating GABAergic neurons.
Asunto(s)
Cannabinoides/metabolismo , Sistema Nervioso Central/metabolismo , Receptores de Droga/metabolismo , Animales , Western Blotting , Encéfalo/anatomía & histología , Encéfalo/metabolismo , Colorantes Fluorescentes , Glutatión Transferasa/metabolismo , Inmunohistoquímica , Masculino , Ratas , Ratas Sprague-Dawley , Receptores de Cannabinoides , Médula Espinal/anatomía & histología , Médula Espinal/metabolismoRESUMEN
The effect of unilateral intrapallidal cannabinoid receptor stimulation on rotational behavior in rats was explored. The potent cannabinoid agonist CP55,940 (5 microg/0.5 microl) induced ipsilateral turning when microinjected unilaterally into the globus pallidus. The D2 dopamine agonist quinpirole reversed this ipsilateral rotation but failed to affect motor behavior on its own. Finally, the D1 dopamine agonist SKF 82958 inhibited movement when administered into the globus pallidus, and this effect was not additive with CP55,940.
Asunto(s)
Agonistas de Dopamina/farmacología , Globo Pálido/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Receptores de Droga/antagonistas & inhibidores , Animales , Conducta Animal/efectos de los fármacos , Benzazepinas/farmacología , Masculino , Quinpirol/farmacología , Ratas , Ratas Sprague-Dawley , Receptores de CannabinoidesRESUMEN
The distribution in the rat brain of fatty acid amide hydrolase (FAAH) an enzyme that catalyzes the hydrolysis of the endogenous cannabinoid anandamide was studied by immunohistochemistry. An immunopurified, polyclonal antibody to the C terminal region of FAAH was used in these studies. The large principal neurons, such as pyramidal cells in the cerebral cortex, the pyramidal cells the hippocampus, Purkinje cells in the cerebellar cortex and the mitral cells in the olfactory bulb, showed the strongest FAAH immunoreactivity. These FAAH-containing principal neurons except the mitral cells in the olfactory bulb are in close proximity with cannabinoid CB1 receptors as revealed by our previous immunohistochemical study. Moderately or lightly stained FAAH-containing neurons were also found in the amygdala, the basal ganglia, the deep cerebellar nuclei, the ventral posterior nuclei of the thalamus, the optic layer and the intermediate white layer of the superior colliculus and the red nucleus in the midbrain, and motor neurons of the spinal cord. These data demonstrate that FAAH is heterogeneously distributed and this distribution exhibits considerable, although not complete, overlap with the distribution of cannabinoid CB1 receptors in rat brain.
Asunto(s)
Amidohidrolasas/análisis , Encéfalo/enzimología , Neuronas/enzimología , Células Piramidales/enzimología , Animales , Corteza Cerebelosa/enzimología , Hipocampo/enzimología , Inmunohistoquímica/métodos , Masculino , Neocórtex/enzimología , Neuronas/clasificación , Neuronas/citología , Bulbo Olfatorio/enzimología , Especificidad de Órganos , Ratas , Ratas Sprague-Dawley , Receptores de Cannabinoides , Receptores de Droga/análisisAsunto(s)
Ganglios Basales/química , Ganglios Basales/citología , Neuronas Motoras/química , Neuronas Motoras/fisiología , Neurotransmisores/fisiología , Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/fisiología , Analgésicos/farmacología , Animales , Ganglios Basales/fisiología , Benzoxazinas , Bicuculina/farmacología , Cannabinoides/antagonistas & inhibidores , Cannabinoides/farmacología , Ciclohexanoles/farmacología , Dopamina/fisiología , Agonistas de Dopamina/farmacología , Electrofisiología , Antagonistas del GABA/farmacología , Morfolinas/farmacología , Neuronas Motoras/efectos de los fármacos , Naftalenos/farmacología , Degeneración Nerviosa/inducido químicamente , Degeneración Nerviosa/fisiopatología , Oxidopamina , Piperidinas/farmacología , Pirazoles/farmacología , Quinpirol/farmacología , Ratas , Rimonabant , Simpaticolíticos , Núcleos Talámicos/citología , Núcleos Talámicos/fisiología , Ácido gamma-Aminobutírico/fisiologíaRESUMEN
The effect of cannabinoids on the excitatory input to the substantia nigra reticulata (SNr) from the subthalamic nucleus was explored. For this purpose a knife cut was performed rostral to the subthalamic nucleus to isolate the subthalamic nucleus and the SNr from the striatum, a major source of cannabinoid receptors to the SNr. The data showed that the cannabinoid agonist WIN55,212-2 blocked the increase in the firing rate of SNr neurons induced by stimulation of the subthalamic nucleus with bicuculline. Furthermore, the cannabinoid antagonist SR141716A antagonized the effect of the cannabinoid agonist. This study showed that cannabinoids regulate not only the striatonigral pathway, as previously reported, but also the subthalamonigral pathway. The opposite influences of these two inputs to the SNr, inhibitory and excitatory respectively, suggest that endogenous cannabinoids play a major role in the physiological regulation of the SNr.
Asunto(s)
Cannabinoides/farmacología , Sustancia Negra/efectos de los fármacos , Núcleos Talámicos/fisiología , Analgésicos/farmacología , Animales , Benzoxazinas , Bicuculina/farmacología , Cannabinoides/antagonistas & inhibidores , Antagonistas del GABA/farmacología , Masculino , Morfolinas/farmacología , Naftalenos/farmacología , Vías Nerviosas/efectos de los fármacos , Vías Nerviosas/fisiología , Piperidinas/farmacología , Pirazoles/farmacología , Ratas , Ratas Sprague-Dawley , Rimonabant , Sustancia Negra/fisiologíaRESUMEN
Human use of marijuana (Cannabis sativa) is widely assumed to have rewarding properties, a notion supported by its widespread recreational use. However, no study has clearly demonstrated such effects in animal models. The purpose of this study was to test for the presumed rewarding effect of cannabinoids using a conditioned place preference paradigm. The results showed that animals failed to develop place conditioning at a low dose (1.5 mg/kg) and developed a place aversion at a high dose (15 mg/kg) of the active principle in marijuana, delta 9-tetrahydrocannabinol (delta 9-THC), a finding consistent with most previous studies. Moreover, the administration of the cannabinoid antagonist SR141716A induced a conditioned place preference at both a low (0.5 mg/kg) and a high (5 mg/kg) dose. In summary, cannabinoid antagonism produced place preference while cannabinoid agonism induced place aversion. These results suggest that endogenous cannabinoids serve normally to suppress reward or to induce aversion.
Asunto(s)
Reacción de Prevención/fisiología , Cannabinoides/metabolismo , Recompensa , Animales , Reacción de Prevención/efectos de los fármacos , Cannabinoides/antagonistas & inhibidores , Condicionamiento Psicológico/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Dronabinol/farmacología , Masculino , Piperidinas/farmacología , Pirazoles/farmacología , Ratas , Ratas Sprague-Dawley , RimonabantRESUMEN
The effect of unilateral intranigral cannabinoid receptor stimulation on rotational behavior was explored. The potent cannabinoid agonist CP 55,940 (5 and 10 micrograms/0.5 microliter) induced contralateral turning when microinjected unilaterally into the substantia nigra pars reticulata. In addition, the cannabinoid agonist markedly attenuated the contralateral rotation induced by the dopamine D1 agonist SKF 82958 and completely reversed the ipsilateral rotation induced by the dopamine D2 agonist quinpirole. In both cases, the coadministration of the cannabinoid agonist together with the D1 or D2 agonist induced contralateral rotation. It appears that cannabinoids may exert different effects depending on the state of the ongoing chemical activation of this brain circuitry.